EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The interplay between TB and lung cancer: risk, prognosis and treatment dynamics

N N Afifah, R Intania, I Wijaya, H Obinata, M I Barliana

The International Journal of Tuberculosis and Lung Disease · 2025

DOI: 10.5588/ijtld.24.0491 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, 2025. Verfasst von N N Afifah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia;, Department of Pharmacy, Faculty of Health Sc…. Hauptthemen laut MEDLINE: Lung Neoplasms, Tuberculosis, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer and TB pose significant global health challenges, especially in low- and middle-income countries (LMICs), where they contribute significantly to morbidity and mortality rates, partly due to high smoking prevalence and delays in diagnosis and treatment. Understanding the association between lung cancer and TB is paramount, as it profoundly affects clinical outcomes and treatment approaches. This review examines the complex relationship between the two conditions, synthesizing findings from 20 studies retrieved through a PubMed search. Individuals with a history of TB disease or TB infection face an elevated risk of developing lung cancer, whereas lung cancer can negatively affect TB prognosis and treatment outcomes. We provide updated insights on the mechanisms underlying this association, and the risk factors for these conditions, to guide future research and enhance clinical management strategies, particularly in LMICs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsTuberculosisTuberculosis, PulmonaryHumansRisk FactorsPrognosisSmokingDeveloping CountriesGlobal Health

Autor:innen und Institutionen

  • Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia;, Department of Pharmacy, Faculty of Health Sciences, Universitas Esa Unggul, Jakarta, Indonesia.
  • Dr. H. A. Rotinsulu Lung Hospital, Bandung, Indonesia.
  • Division of Hematology and Medical Oncology, Department of Internal Medicine, Hasan Sadikin General Hospital, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia.
  • Education and Research Support Center, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
  • Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia;, Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Jatinangor, Indonesia.

Zitieren

APA

Afifah, N. N., Intania, R., Wijaya, I., Obinata, H., & Barliana, M. I. (2025). The interplay between TB and lung cancer: risk, prognosis and treatment dynamics. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.24.0491

Vancouver

Afifah NN, Intania R, Wijaya I, Obinata H, Barliana MI. The interplay between TB and lung cancer: risk, prognosis and treatment dynamics. The International Journal of Tuberculosis and Lung Disease. 2025. doi:10.5588/ijtld.24.0491

BibTeX
@article{Afifah2025,
  author = {Afifah, N N and Intania, R and Wijaya, I and Obinata, H and Barliana, M I},
  title = {The interplay between TB and lung cancer: risk, prognosis and treatment dynamics},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2025},
  doi = {10.5588/ijtld.24.0491}
}
Kostenlos starten →